» Articles » PMID: 7327198

Activation of Mouse Complement by Monoclonal Mouse Antibodies

Overview
Journal Eur J Immunol
Date 1981 Dec 1
PMID 7327198
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of monoclonal mouse IgM, IgD and IgG anti-(4-hydroxy-3-nitrophenyl) acetyl (NP) antibodies to activate mouse complement was studied using a hemolytic assay. Efficient hemolysis was obtained with IgG2a, IgG2b and IgG3 antibodies but no lysis was observed using a monoclonal IgD. Of several IgG1 antibodies tested, three gave no detectable hemolysis, although weak but significant hemolysis was obtained with two other IgG1. IgM was found to be powerfully hemolytic in that it was effective at lower concentrations than were IgG. However, using complement from mouse strains carrying the H-2k haplotype it was found that, under conditions of complement limitation and saturating antibody, a fixed amount of complement could lyse about 3 to 4 times as many IgG-coated sheep red cells as IgM-coated red cells. This discrimination between IgM and IgG as regards the efficiency of complement utilization is controlled by a gene in the S region of H-2 and is not apparent with complement from mice carrying the b, d or s allele at that locus.

Citing Articles

Immunoprotection Provided by Salivary and Intestinal Protein-Based Antigens Against the Ixodid Tick .

Natividade U, Abreu J, Ribeiro I, Pereira Filho A, Silva A, Ribeiro H Vaccines (Basel). 2025; 13(2).

PMID: 40006683 PMC: 11860927. DOI: 10.3390/vaccines13020136.


Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections.

Cardoso K, de Souza L, da Silva Santos B, de Carvalho K, da Silva Messias S, de Faria Goncalves A NPJ Vaccines. 2024; 9(1):246.

PMID: 39702744 PMC: 11659394. DOI: 10.1038/s41541-024-01033-5.


Skin autonomous antibody production regulates host-microbiota interactions.

Gribonika I, Band V, Chi L, Perez-Chaparro P, Link V, Ansaldo E Nature. 2024; 638(8052):1043-1053.

PMID: 39662506 PMC: 11864984. DOI: 10.1038/s41586-024-08376-y.


Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza.

Cui X, Vervaeke P, Gao Y, Opsomer L, Sun Q, Snoeck J NPJ Vaccines. 2024; 9(1):138.

PMID: 39097672 PMC: 11298010. DOI: 10.1038/s41541-024-00932-x.


Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.

Zimmermann J, van Haren S, Diray-Arce J, Adriawan I, Worzner K, Krog R NPJ Vaccines. 2023; 8(1):189.

PMID: 38135685 PMC: 10746746. DOI: 10.1038/s41541-023-00781-0.